FibroGenesis is a regenerative medicine company developing an innovative solution for degenerative disc disease using human dermal fibroblasts. Currently, FibroGenesis holds 150+ U.S. and international issued patents issued/pending. FibroGenesis represents the next generation of medical advancement in cell therapy.
| Website | http://www.spinalcyte.com |
| Revenue | $1 million |
| Employees | 1 (1 on RocketReach) |
| Address | 16815 Royal Crest Dr, Houston, Texas 77030, US |
| Phone | +1 281-461-6211 |
| Fax | (281) 461-6213 |
| Industry | Biotechnology Research, Drug Manufacturing & Research, Medical, Pharmaceuticals, Health Care, Healthcare, Therapeutics |
| Keywords | Regenerative Medicine, Degenerative Disc Disease, Cell Therapy, Tissue Engineering, Spine, Disc Replacement, Intervertebral Disc, Regenerative Therapies, Biologics, Medical Devices, Patented Technology, Clinical Trials, Fda Approval, Drug Development, Orthopedic Surgery, Musculoskeletal |
| Competitors | Pharvaris, CollPlant, ViaCyte, InGeneron, DiscGenics, Regeneus Ltd, Lineage Cell Therapeutics, VIDEREGEN LIMITED (view competitors) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular SpinalCyte, LLC employee's phone or email?
SpinalCyte, LLC Questions
The SpinalCyte, LLC annual revenue was $1 million in 2026.
1 people are employed at SpinalCyte, LLC.
SpinalCyte, LLC is based in Houston, Texas.
The NAICS codes for SpinalCyte, LLC are [54171, 54, 5417, 541714, 541].
The SIC codes for SpinalCyte, LLC are [87, 873].
Top SpinalCyte, LLC Employees
Related Companies
